Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery
- PMID: 21788069
- DOI: 10.1016/j.biomaterials.2011.07.004
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery
Abstract
Targeted delivery of therapeutic nanoparticles in a disease-specific manner represents a potentially powerful technology especially when treating infiltrative brain tumors such as gliomas. We developed a nanoparticulate drug delivery system decorated with AS1411 (Ap), a DNA aptamer specifically binding to nucleolin which was highly expressed in the plasma membrane of both cancer cells and endothelial cells in angiogenic blood vessels, as the targeting ligand to facilitate anti-glioma delivery of paclitaxel (PTX). Ap was conjugated to the surface of PEG-PLGA nanoparticles (NP) via an EDC/NHS technique. With the conjugation confirmed by Urea PAGE and XPS, the resulting Ap-PTX-NP was uniformly round with particle size at 156.0 ± 54.8 nm and zeta potential at -32.93 ± 3.1 mV. Ap-nucleolin interaction significantly enhanced cellular association of nanoparticles in C6 glioma cells, and increased the cytotoxicity of its payload. Prolonged circulation and enhanced PTX accumulation at the tumor site was achieved for Ap-PTX-NP, which eventually obtained significantly higher tumor inhibition on mice bearing C6 glioma xenografts and prolonged animal survival on rats bearing intracranial C6 gliomas when compared with PTX-NP and Taxol(®). The results of this contribution demonstrated the potential utility of AS1411-functionalized nanoparticles for a therapeutic application in the treatment of gliomas.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.Biomaterials. 2013 Jul;34(22):5640-50. doi: 10.1016/j.biomaterials.2013.04.025. Epub 2013 Apr 29. Biomaterials. 2013. PMID: 23639530
-
iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.Biomaterials. 2014 May;35(14):4319-32. doi: 10.1016/j.biomaterials.2014.01.082. Epub 2014 Feb 22. Biomaterials. 2014. PMID: 24565520
-
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.Biomaterials. 2013 Jan;34(1):196-208. doi: 10.1016/j.biomaterials.2012.09.044. Epub 2012 Oct 12. Biomaterials. 2013. PMID: 23069707
-
Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.Biomacromolecules. 2014 Jun 9;15(6):1955-69. doi: 10.1021/bm5003009. Epub 2014 May 12. Biomacromolecules. 2014. PMID: 24798476 Review.
-
Indotricarbocyanine-loaded AS1411 DNA aptamer- and TGN peptide-modified poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles.2012 Aug 10 [updated 2012 Sep 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Aug 10 [updated 2012 Sep 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22973579 Free Books & Documents. Review.
Cited by
-
Nanotechnology-novel therapeutics for CNS disorders.Nat Rev Neurol. 2012 Apr 24;8(6):307-18. doi: 10.1038/nrneurol.2012.76. Nat Rev Neurol. 2012. PMID: 22526003 Free PMC article. Review.
-
Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy.Int J Nanomedicine. 2019 Dec 2;14:9483-9496. doi: 10.2147/IJN.S224160. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31819445 Free PMC article.
-
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond.Neurotherapeutics. 2019 Apr;16(2):319-347. doi: 10.1007/s13311-018-00702-3. Neurotherapeutics. 2019. PMID: 30644073 Free PMC article. Review.
-
Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment.Nanoscale Res Lett. 2013 Oct 17;8(1):420. doi: 10.1186/1556-276X-8-420. Nanoscale Res Lett. 2013. PMID: 24134303 Free PMC article.
-
Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System.Pharmaceutics. 2020 Feb 23;12(2):192. doi: 10.3390/pharmaceutics12020192. Pharmaceutics. 2020. PMID: 32102252 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous